Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | AMRN | RVNC | NKTX | ||
Company | Amarin Corp ADR | Revance Therapeutics | Nkarta Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.8800 | 3.64 | 7.50 | ||
High | 0.8894 | 3.75 | 7.56 | ||
Low | 0.8655 | 3.54 | 7.02 | ||
Last | 0.8786 | 3.57 | 7.17 | ||
Change | -0.0047 | -0.09 | -0.39 | ||
% Change | -0.53% | -2.46% | -5.16% | ||
Volume | 667,300 | 1,789,000 | 675,900 | ||
20-Day Average Volume | 1,292,080 | 1,585,450 | 1,081,695 | ||
Previous Close | 0.8833 | 3.66 | 7.56 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.9530 | 4.23 | 8.78 | ||
20-Day Raw Stochastic | 10.31% | 2.07% | 3.11% | ||
20-Day Relative Strength | 42.86% | 32.10% | 38.73% | ||
Weighted Alpha | -45.39 | -85.61 | +3.58 | ||
Today's Opinion | 56% Sell | 100% Sell | 24% Buy | ||
Previous Opinion | 40% Sell | 100% Sell | 24% Buy | ||
Last Month's Opinion | 56% Sell | 88% Sell | 56% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -4.20% since 04/17/24 | -5.05% since 04/17/24 | -8.78% since 04/17/24 | ||
Low | 0.8593 on 04/19/24 | 3.54 on 04/24/24 | 7.02 on 04/24/24 | ||
High | 0.9600 on 04/18/24 | 3.87 on 04/22/24 | 7.96 on 04/19/24 | ||
1-Month | |||||
%Chg | +2.20% since 03/22/24 | -26.69% since 03/22/24 | -19.62% since 03/22/24 | ||
Low | 0.8339 on 03/25/24 | 3.54 on 04/24/24 | 7.02 on 04/24/24 | ||
High | 1.1100 on 04/09/24 | 5.03 on 03/28/24 | 11.84 on 04/01/24 | ||
3-Month | |||||
%Chg | -23.60% since 01/24/24 | -37.48% since 01/24/24 | -13.61% since 01/24/24 | ||
Low | 0.8015 on 03/14/24 | 3.54 on 04/24/24 | 7.02 on 04/24/24 | ||
High | 1.3700 on 01/30/24 | 7.56 on 03/01/24 | 16.24 on 03/07/24 | ||
6-Month | |||||
%Chg | +15.56% since 10/24/23 | -58.73% since 10/24/23 | +265.82% since 10/24/23 | ||
Low | 0.6510 on 11/01/23 | 3.54 on 04/24/24 | 1.86 on 10/30/23 | ||
High | 1.3700 on 01/30/24 | 9.74 on 01/02/24 | 16.24 on 03/07/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 360,816 | 372,051 | 354,313 | ||
Shares Outstanding, K | 410,672 | 104,216 | 49,416 | ||
Annual Sales | 306,910,000 | 234,040,000 | 0 | ||
Annual Net Income | -59,110,000 | -323,990,000 | -117,500,000 | ||
Last Quarter Sales | 74,710,000 | 69,800,000 | 0 | ||
Last Quarter Net Income | -5,780,000 | -55,700,000 | -27,750,000 | ||
60-Month Beta | 1.98 | 1.05 | 0.70 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.00 on 02/29/24 | -0.62 on 02/28/24 | -0.57 on 03/21/24 | ||
Latest Earnings Date | 05/01/24 | 05/14/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |